In this session Far East Gold’s CEO and Director Shane Menere and newly appointed Non-Executive Chairman Justin Werner discussed what the potentially transformative Idenburg acquisition could mean for Far East Gold.

In this session MDF’s Managing Director Joseph Webb discussed how MDF’s team, who have made discoveries worth $100 billion in planned and actual production, are planning to deliver tier 1 copper projects.

In this session Felix Gold Executive Director Joseph Webb discussed their plans to grow and develop NW Array’s 467koz resource.

Hedley tells the story of Plutonic, presenting their initial thesis, work to date, as well as terms and use of funds of the capital raise.

Hedley Widdup, CEO of leading resources fund manager Lion Selection Group (ASX:LSX), discusses why he believes that Plutonic represents a “once in a cycle” opportunity, elaborating on their progress and pathway to IPO.

Plutonic founder Dr Kris Butera discusses his flagship Champion project, expanding on why he believes there is potential for a resource deposit that is “unlike anything he has ever seen.” Kris talks through his team’s four year exploration journey and provides examples of the mineralisation present within the high priority prosepect areas.

In this session Far East Gold’s CEO and Director Shane Menere discussed the standout assays from our Woyla drilling campaigns that form the base of our upcoming maiden JORC resource publication.

In this session Prescient CEO and Managing Director Steven Yatomi-Clarke discussed why the data from their PTX-100 Phase 1b trial is so promising.

In this session Prescient CEO and Managing Director Steven Yatomi-Clarke provide a company update on strategy and upcoming milestones.

Join Stuart Roberts, co-founder and senior analyst at Pitt Street Research, for an online briefing where he will outline the recent Pitt Street Research report on Prescient Therapeutics.

In this session Far East Gold’s CEO and Director Shane Menere discussed, why the Board (including Nickel Industries MD Justin Werner) is optimistic about the findings so far……

In this session Wellnex Life MD Zack Bozinovski and Non-Executive Chairman Mario Tascone discussed what attracted Mario to Wellnex and where he sees the future of the business;